Exsure is working on a way to make chemotherapy less toxic, backed by peer-reviewed research

The Bhubaneswar biotech has built a patented drug-delivery platform aimed at cancer cells. It is in preclinical testing and raised Rs 3 crore, led by Unicorn India Ventures.